The average price paid by hospitals for cardiac implantable resynchronization pacemakers has dropped 12% over the last year, according to the most recent Modern Healthcare/ECRI Institute Technology ...

MILAN, Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the launch of REPLY CRT-P, its new cardiac resynchronization therapy ...

Analysts believe that device makers who are able to launch implantable products whose functioning isn’t hampered by magnetic resonance imaging will win as chronically ill patients are often directed ...

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced approval from the U.S. Food and Drug Administration (FDA) for the Allure Quadra ™ ...

Please provide your email address to receive an email when new articles are posted on . A leadless pacemaker can deliver cardiac resynchronization therapy to patients who cannot have conventional CRT ...

MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P. The Viva CRT-P is ...

Please provide your email address to receive an email when new articles are posted on . Biotronik announced that it has launched the smallest MR conditional cardiac resynchronization therapy pacemaker ...

BIOTRONIK has unveiled its brand new Edora pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps) following CE Mark approval in Europe. These devices feature BIOTRONIK’s ProMRI ...

ROCHESTER, NY — Some patients with "normalized" LV function when their primary-prevention defibrillating cardiac-resynchronization-therapy device (CRT-D) nears the end of its service life may safely ...

Pacemakers do not result in lower survival than implantable cardiac defibrillator (ICD) devices in patients undergoing cardiac resynchronization therapy (CRT) for heart failure, a large health claims ...

MILAN--(BUSINESS WIRE)--Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the launch of REPLY CRT ...